Stocks
Structure Therapeutics Inc.GPCR
NASDAQHealthcareBiotechnology$53.75-1.52%
Focused on developing novel therapeutics targeting G protein-coupled receptors (GPCRs), this biopharmaceutical firm leverages structural biology and computational chemistry. Its lead candidates address metabolic and pulmonary diseases, attracting investor interest in its structure-based drug design platform.
Market Cap: $3.1B52W Range: $13.22 – $94.90
Congressional Interest in Structure Therapeutics Inc. (GPCR)
1 member of Congress has disclosed 1 trade in Structure Therapeutics Inc. (GPCR), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading GPCR?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-10-04 | Thomas R Carper | sell | $1K – $15K |